|FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C.  20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIESFiled pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public UtilityHolding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 | OMB APPROVALOMB Number: 3235-0104Expires: December 31, 2001Estimated average burdenhours per response. . . . . 0.5
|------ | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------

|1. Name and Address of Reporting Person*Hardwick, Charles     L.(Last)                      (First)                      (Middle)Pfizer Inc.    Att:  Corporate Secretary235 East 42nd Street(Street)New York, NY     10017(City)                      (State)                      (Zip) | 2. Date of Event    Requiring Statement   (Month/Day/Year)July 01, 20023. I.R.S. Identification    Number of Reporting    Person, if an entity    (voluntary) | 4. Issuer Name and Ticker or Trading SymbolPfizer Inc   (PFE)5. Relationship of Reporting Person(s) to Issuer(Check all applicable) Director    10% OwnerX Officer      OtherOfficer/OtherDescription           Senior Vice President | 6. If Amendment, Date of    Original (Month/Day/Year)7. Individual or Joint/Group     Filing (Check Applicable Line)X   Individual Filing   Joint/Group Filing
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

|Table I - Non-Derivative Securities Beneficially Owned
|------------------------------------------------------

|1. Title of Security    (Instr. 4) | 2. Amount of Securities Beneficially Owned     (Instr. 4) | 3. Ownership Form :     (D) Direct     (I) Indirect     (Instr. 5) | 4. Nature of Beneficial Ownership     (Instr. 5)
|---------------------------------- | --------------------------------------------------------- | ------------------------------------------------------------------ | ------------------------------------------------
|Common Stock                       | 7,789                                                     | D                                                                  |                                                 
|Common Stock                       | 39,242                                                    | I                                                                  | By Rule 16b-3 Plan                              
|                                   |                                                           |                                                                    |                                                 

|
|

|
|

|Hardwick, Charles L. - July 2002
|--------------------------------

|Form 3 (continued)
|------------------

|Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|------------------------------------------------------------------------------------------------------------------

|1. Title of Derivative Security     (Instr. 4) | 2. Date Exercisable(DE) and Expiration Date(ED)(DE)     |     (ED) | 3. Title and Amount of of Underlying Security     (Instr. 4) | 4. Conversion or     Exercise Price | 5. Ownership     Form     (D) Direct     or     (I) Indirect     (Instr. 5) | 6. Nature of Indirect     Beneficial Ownership     (Instr. 5)
|---------------------------------------------- | ------------------------------------------------------------------ | ------------------------------------------------------------ | ----------------------------------- | --------------------------------------------------------------------------- | -------------------------------------------------------------
|Employee Stock Option (right to buy)           | (1) | 08/27/2007                                                   | Common Stock - 9,998                                         | $18.35                              | D                                                                           |                                                              
|Employee Stock Option (right to buy)           | (2) | 08/26/2008                                                   | Common Stock - 66,000                                        | $35.21                              | D                                                                           |                                                              
|Employee Stock Option (right to buy)           | (3) | 04/21/2009                                                   | Common Stock - 72,450                                        | $42.07                              | D                                                                           |                                                              
|Employee Stock Option (right to buy)           | (4) | 02/23/2010                                                   | Common Stock - 44,000                                        | $32.94                              | D                                                                           |                                                              
|Employee Stock Option (right to buy)           | (5) | 02/21/2011                                                   | Common Stock - 44,500                                        | $45.34                              | D                                                                           |                                                              
|Employee Stock Option (right to buy)           | (6) | 02/27/2012                                                   | Common Stock - 50,000                                        | $41.30                              | D                                                                           |                                                              
|Phantom Stock Units (SSP)                      | Immed. | (7)                                                       | Common Stock - 2,376                                         | 1-for-1                             | D                                                                           |                                                              
|                                               |                                                                    |                                                              |                                     |                                                                             |                                                              

|** Intentional misstatements or
      omissions of facts constitute Federal Criminal Violations.
              See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
      Note:   File three copies of this Form, one of which must be manually
      signed. If space is insufficient,
                  See Instruction 6 for procedure.
      Potential persons who are to respond to the collection of information contained
      in this form are not
      required to respond unless the form displays a currently valid OMB number. | /s/ Lawrence A. Fox forCharles
        L. Hardwick                       July
        1, 2002 
        ** Signature of Reporting Person            
                    DateLawrence A. Fox for
        Charles L. Hardwick
      Page 2
        SEC 1473 (3-99)
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                                                                                 

|
|

|Hardwick, Charles L. - July 2002
|--------------------------------

|Form 3 (continued)
|------------------

|FOOTNOTE Descriptions for Pfizer Inc (PFE)
Form 3 - July 2002
Charles L. HardwickPfizer Inc.    Att:  Corporate Secretary235 East 42nd StreetNew York, NY 10017Explanation of responses:(1)   The option became exercisable in 5 equal annual installments beginning on August 28,1998.(2)   The option became exercisable in 5 equal annual installments beginning on August 28, 1999.(3)   The option became exercisable in 5 equal annual installments beginning on April 23, 2000.(4)   The option became exercisable in 5 equal annual installments beginning on February 24, 2001.(5)   The option became exercisable in 5 equal annual installments beginning on February 25, 2002.(6)   This option becomes exercisable in 5 equal annual installments beginning on February 28, 2003.(7)   These units are settled in cash following the reporting person's separation from service.
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|Page 3
|------